New product: Nustendi (bempedoic acid/ezetimibe) 180mg/10mg film-coated tablets

Nustendi is licensed for treatment of adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet, either as monotherapy or in combination with a statin.

SPS commentary:

Bempedoic acid lowers low-density lipoprotein cholesterol by inhibiting cholesterol synthesis in the liver.


electronic Medicines compendium